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Abstract
Background: Recent studies suggest reduction of radical-propagating fatty acid hydroperoxides to inert hydroxides by
interaction with apolipoprotein-D (apoD) Met93 may represent an antioxidant function for apoD. The nature and structural
consequences of this selective interaction are unknown.
Methodology/Principal Findings: Herein we used molecular dynamics (MD) analysis to address these issues. Long-
timescale simulations of apoD suggest lipid molecules are bound flexibly, with the molecules free to explore multiple
conformations in a binding site at the entrance to the classical lipocalin ligand-binding pocket. Models of 5s- 12s- and 15s-
hydroperoxyeicosatetraenoic acids were created and the lipids found to wrap around Met93 thus providing a plausible
mechanism by which eicosatetraenoic acids bearing hydroperoxides on different carbon atoms can interact with Met93 to
yield Met93 sulfoxide (Met93SO). Simulations of glycosylated apoD indicated that a second solvent exposed Met at position
49 was shielded by a triantennerary N-glycan attached to Asn45 thereby precluding lipid interactions. MD simulations of
apoD showed B-factors of the loop containing Met93SO were higher in the oxidized protein, indicating increased flexibility
that is predicted to destabilize the protein and promote self-association.
Conclusions/Significance: These studies provide novel insights into the mechanisms that may contribute to the antioxidant
function of apoD and the structural consequences that result if Met93SO is not redox-cycled back to its native state.
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Introduction
Apolipoprotein-D (apoD) is a 29 kDa glycoprotein member of the
lipocalin family that comprises an eight-stranded antiparallel b-barrel
flanked byana-helix [1]. The b-barrel encloses a hydrophobic ligand
pocket that binds arachidonic acid and progesterone with high
affinity [1,2]. The eicosanoids 12-hydroxyeicosatetraenoic acid (12-
HETE) and 5,15- dihydroxyeicosatetraenoic acid have also been
shown to bind to apoD albeit with lower affinity [3–5]. In addition to
the classical lipocalin pocket [6], apoD may also interact with lipids
via a cluster of exposed hydrophobic residues residing in three of its
extended loops [1]. These exposed residues generate a hydrophobic
surface region close to the open end of the binding pocket that
facilitates apoD association with high-density lipoprotein (HDL)
particles and is also thought to permit insertion of apoD into cellular
lipid membranes [1].
Although apoD is well known to bind lipids and thereby thought
to play a role in lipid transport in the brain and in plasma [7], it
has also more recently been associated with lipid antioxidant
protection. This has been clearly demonstrated using apoD null
and apoD over-expressing mice [8] and in an ageing Drosophila
model [9]. In these studies apoD overexpression protected against
insults that promote cerebral lipid peroxidation whereas deletion
of the APOD gene increased susceptibility to oxidative stress. This
antioxidant function might also explain why apoD levels are
increased in the human brain in association with ageing and
Alzheimer’s disease [10–12] as it could serve as a protective
response to combat the increased levels of lipid peroxidation that
are know to occur under these conditions [13,14].
We have recently shown that apoD catalyzes the reduction of
potential free-radical generating lipid hydroperoxides (L-OOHs) to
relatively inert lipid hydroxides (L-OHs) via a selective interaction with
apoD Met93 [15]. As a consequence of this reaction Met93 is selectively
converted to MetSO [15]. We have proposed that this reduction of L-
OOH to L-OH competes with transition metal-catalyzed Fenton-type
reactions that could otherwise generate chain-propagating radicals
from L-OOHs [15]. Although this pathway may contribute to the
apoD antioxidant mechanism, it is presently unclear how different lipid
hydroperoxides may interact selectively with apoD Met93 when high
affinity lipid binding within the apoD ligand pocket is known to be
selective [2]. In addition, details of the structural changes that may
occur in apoD as a result of Met93SO generation remain to be defined.
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e34057Figure 1. ApoD Clustal alignment. ApoD sequences were aligned using the UniProt Consortium Clustal alignment tool for the listed mammalian
species. The positions of the three human Met residues are annotated (using the human residue numbering without the 20 amino acid signal
peptide). Conserved Met residues are highlighted in yellow with substituted amino acids highlighted in red.
doi:10.1371/journal.pone.0034057.g001
Molecular Dynamics Analysis of Apolipoprotein-D
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e34057The aim of the present study was therefore to use MD
simulations and molecular modeling approaches to investigate the
interactions of arachidonic acid and its lipoxygenase-derived
HpETE products with apoD and to assess the potential structural
consequences of apoD Met93 oxidation.
Materials and Methods
ApoD molecular dynamics simulations and modelling
In order to understand the structural basis for the behavior of
apoD, modeling and MD simulations were performed. All MD
trajectories were calculated using NAMD 2.8 [16]. For all
simulations of apoD, models were embedded in a water box with
overlapping water molecules removed and sodium ions added to
ensure that the systems had no net charge. Temperature control at
310 K was maintained with Langevin dynamics (damping
constant: 5 ps
21) applied to non-hydrogen atoms. Periodic
boundary conditions were used with the Nose ´-Hoover Langevin
piston method (piston period 100 fs, decay rate 50 fs) to maintain
a constant pressure of 1.013 Bar. The Particle-mesh Ewald
algorithm was used to account for long-range electrostatic effects
(grid resolution,1A ˚). All other non-bonded interactions were
calculated using a switching function to smooth interactions to
zero between 10 and 12 A ˚. The integration timesteps were 1, 2,
and 4 fs for bonded, nonbonded, and long-range electrostatic
interactions respectively. Every system was initially equilibrated for
100 ps, after which the MD run was extended as described below.
Coordinates were saved every 1 ps for analysis.
To determine the effects of Met93 oxidation on stability of
apoD, 50 ns simulations of apoD and ApoD-Met93SO without
bound ligands were calculated. The starting configuration for
these calculations was the published structure of ligand-free apoD
(PDB: 2HZR), with missing residues modeled, selenoMet residues
changed to Met and any mutated residues reverted to wild-type.
To assess the ability of the simulations to reproduce native protein-
ligand conformations, a 100 ns simulation of the complex of apoD
with progesterone was performed using the crystal structure of this
complex (PDB: 2HZQ) for the starting configuration. To
understand the behavior of lipid molecules bound to apoD, four
200 ns runs were produced with arachidonic acid modeled in the
binding site in different extended conformations. Low energy
conformations were used to model arachidonate metabolites 5s-,
12s- and 15s-HpETE bound to apoD. Finally, a 50 ns simulation
of the apoD-progesterone complex with experimentally deter-
mined glycosylation was performed. In all cases the CHARMM
protein force field [17] with backbone 2D dihedral energy
correction (CMAP) [18] was used. Parameters for MetSO were
adapted from parameters for DMSO [19]. The CHARMM
general force-field [20] and carbohydrate derivative forcefield [21]
was used for progesterone and glycosylations respectively.
Trajectory data were analyzed using VMD [22]. Protein-ligand
interaction energies were estimated using the generalized Born
implicit solvent model [23]. Energies of isolated protein and ligand
entities were calculated and subtracted from the energy of the
combined system. For modeling HpETE compounds, parameters
Figure 2. ApoD structure. (A) Orthogonal views of apoD in cartoon form with progesterone bound. The ligand and methionine residues are
represented as van der Waals spheres. (B) Same as (A) but with protein represented as a solvent-accessible surface. Methionine residues (red patches)
and glycosylated asparagine residues (green patches) are indicated.
doi:10.1371/journal.pone.0034057.g002
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[20] or were derived from ab inito calculations on the model
compound 2-hydroperoxypropane using Gaussian09 [24], per-
formed at the MP2/6-31G* level of theory.
ApoD analysis by circular dichroism (CD)
Recombinant forms of human apoD (NM_001647.3) containing
a C-terminal linker, FLAG-tag and poly His tail (SGGG
GSDYKDDDDKHHHHHH) were synthesized in HEK293 cells
(American Type Culture Collection (ATCC), Catalogue No. CRL-
1573, Manassas, VA, USA) and purified using a Ni-HiTrap column
as described previously [15]. To generate apoD containing
Met93SO, wild type apoD (0.5 mg/ml) was incubated in PBS
containing 15s-HpETE (0.05 mg/ml) for 4 h. The protein fraction
was precipitated with 9 volumes of ice-cold ethanol for 1 h at 220u
and the pellet re-suspended in 20 ml of PBS in preparation for CD
analysis. Far UV CD spectra for apoD and its mutants (apoD, M49-
A, M93-A, M157-A) were acquired using Jasco J-810 CD
spectropolarimeter at 22uC. Protein samples were prepared to final
concentration of 0.1 mg/ml in PBS and spectra recorded using
0.1 cm quartz cuvette. Measurements were taken from 195–
260 nm using a scan speed of 100 nm/min, 1 nm bandwidth, 1 s
response time and data pitch of 0.1 nm. Each spectrum is an
average of6 scansandcorrected bysubtraction ofthePBS spectrum
acquired under similar conditions.
Results
ApoD structure and position of Met residues
We first examined apoD amino acid sequence across a variety of
mammalian species. ApoD contains three Met residues that are
highly conserved (Figure 1). In humans, apoD Met residues are
Met49, Met93 and Met157. Met93 is located in a hydrophobic region
at the opening of the ligand-binding pocket and is clearly exposed to
the surface (Figure 2). Met49 is also exposed to the surface, residing
within a b-strand stretch four amino acids C-terminal to one of the
twoN-linked glycosylationsites(Asn45). Met157appearstobelargely
buried beneath a surface-accessible a-helix (Figure 2).
MD simulation of apoD interactions with progesterone
and arachidonic acid
In a recent study we reported that apoD exhibits a lipid
antioxidant activity that we propose is due to the direct interaction
of the apoD Met93 side chain with lipid hydroperoxides such as 5s-,
12s- and 15s-HpETEs [15]. Previous work indicated the high
affinity binding of lipids within the apoD ligand binding pocket is
selective and it was therefore unclear how different lipid
hydroperoxides may interact with Met93.
We first assessed the interaction of progesterone with apoD as
crystallography studies indicate this lipid forms a stable complex
within the ligand-binding pocket [1]. In a 100 ns simulation of
progesterone bound to apoD, the ligand remained close to the
crystallographic conformation, with binding energies fluctuating
between 21 and 223 kcal/mol (Figure 3). The RMSD of ligand
atoms with respect to the crystallographically observed conforma-
tion was between 2 and 3.5 A ˚. A small degree of lateral sliding of
the ligand in the pocket was observed in our MD simulation. All
crystallographically observed contacts between progesterone and
apoD were maintained over 100 ns.
We next examined the interaction of arachidonic acid with
apoD. Four simulations of apoD with bound arachidonic acid,
Figure 3. MD simulation of apoD with progesterone. (A) Orthogonal views of apoD in ribbon form with ligand-binding residues shown (cyan
carbon atoms). The conformation of progesterone, sampled at 1 ns intervals, is shown (black carbon atoms). Methionine residues are represented as
van der Waals spheres. (B) Interaction energy is plotted as a function of time.
doi:10.1371/journal.pone.0034057.g003
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opening of the ligand binding pocket and that this hydrophobic
surface appears to behave as a ‘‘greasy slide’’. In none of the four
simulations, did arachidonate converge on a particular bound
conformation (Figure 4). Instead, arachidonate continuously
explores conformational space. In the majority of conformations
sampled, arachidonate is extended length-ways across the binding
site or is partly curled up in the binding site. In simulation 3,
arachidonate became partly unbound but re-entered the binding
site. In simulation 4, the tail of arachidonic acid became
transiently buried in the binding site in a manner reminiscent of
progesterone. Also in simulation 4, arachidonate adopted a
conformation with low energy of interaction lasting approximately
30 ns (Figure 5), in which the carboxylic acid group of the fatty
acid engaged in a salt bridge interaction with Arg62, with the
remainder of the molecule lying in the binding site in a crescent-
shaped conformation wrapped around Met93. This population of
low-energy arachidonate conformations was used to model
binding of 5s-, 12s- and 15s-HpETE to apoD.
Modeling of HpETE interaction with apoD
The absence of appropriate parameters for lipid hydroperoxides
in the CHARMM force-field currently precludes simulation of this
class of molecule with apoD. Nevertheless, in order to understand
how L-OOHs might bind to apoD, the peroxidized arachidonate
products 5s-, 12s-, and 15s-HpETE were modeled based on the
most stable low-energy conformation observed for arachidonate.
The models are shown overlaid in Figure 6. These models suggest
that the L-OOH molecules wrap around Met93 thus providing a
plausible mechanism by which eicosatetraenoic acids bearing
peroxides on different carbon atoms can interact with Met93 and
give rise to Met93SO.
MD simulations of glycosylated apoD – Met49 is shielded
Data derived from our previous studies [15] and the simulations
above clearly indicate that HpETEs can interact with Met93. The
side-chain of Met157 is buried and a lack of interaction between
this residue and L-OOHs is therefore expected. However, Met49 is
relatively exposed in the crystal structure (Figure 2A) and was
observed to interact with solvent in the simulations described
above. It was therefore unclear why the interaction of HpETEs
with apoD do not generate Met49SO. Given the location of N-
glycan structures at Asn45 and Asn78 [25], we hypothesized that
the N-glycan moiety at Asn45 might shield Met49 and prevent L-
OOH mediated Met oxidation. We therefore ran an extended
Figure 4. MD simulation of apoD with arachidonate. Orthogonal
views of apoD in ribbon form with ligand-binding residues shown (cyan
carbon atoms). The conformation of arachidonate, sampled at 1 ns
intervals, is shown for simulations 1 to 4 (black carbon atoms).
Methionine residues are represented as van der Waals spheres.
doi:10.1371/journal.pone.0034057.g004
Figure 5. Interaction energy for MD simulation of apoD with
arachidonate. Interaction energy of the four runs shown in Figure 4
are plotted as a function of time. The conformations in Figure 4
simulation 4 used for modeling of HpETE are indicated by a bar.
doi:10.1371/journal.pone.0034057.g005
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present at Asn45 and Asn78 have been previously characterized
and found to be mostly represented by trisialo triantennary and
fucosylated disialo biantennary oligosaccharides, respectively [25],
as graphically represented in Figure 7A. The conformations of the
N-glycan chains are represented in Figure 7B. Clearly, access to
Met49 is partially blocked by the trisialo triantennary N-glycan at
Asn45 whereas neither of the N-glycans obstruct access to the
apoD ligand binding pocket (Figure 7B). This provides a plausible
explanation for the previously reported lack of reactivity between
the apoD Met49 side chain and various HpETEs [15].
CD analysis indicates MetSO formation does not induce
major structural changes
The above simulations give a plausible explanation for the
selective oxidation of Met93 by L-OOHs. Based on this
information and on our previous observations that the formation
of Met93SO promotes apoD self-association and aggregation [15],
we went on to investigate the possible structural changes that may
be induced by apoD Met93SO formation. The CD spectrum of
recombinant wild type apoD and all three Met to Ala mutants
shows a negative minima in ellipticity at 208 nm (Figure 8) and
overall is in very close agreement with previous studies [26].
Furthermore, the CD spectrum of HpETE-treated apoD (previ-
ously shown to convert apoD Met93 to Met93SO, [15]) was very
similar to both the wild type apoD and the Met to Ala mutants
(Figure 8). This indicates that neither mutation of apoD Met
residues to Ala nor conversion of Met93 to Met93SO induce major
changes to apoD secondary structure and, in particular, that the b-
barrel structure remains in tact.
MD simulaltion of apoD and apoD-Met93SO shows
increased mobility in response to Met93 oxidation
Because no major changes in apoD secondary structure were
detected by CD spectroscopy, we next used MD simulations to
probe for structural changes that may be induced by apoD
Met93SO formation. ApoD and apoD-Met93SO were simulated
for 50 ns. The proteins were stable over that timeframe. In both
simulations the RMSD of Ca atoms initially increased and
stabilized at around 2–2.5 A ˚ (data not shown). Calculated B-
factors from the simulations matched the pattern of B-factors in
the X-ray structure (PDB: 2HZQ) (Figure 9A). The B-factors of
the loop containing Met93SO were higher in the simulation of the
oxidized protein, indicating increased flexibility. In the apoD
simulation, Met93 remained associated with the side-chains of
Phe89 and Phe92 via hydrophobic interactions. In the apoD-
Met93SO simulation, the side-chain displayed more flexibility.
Initially, the side-chain sulfoxide oxygen atom accepted hydrogen
Figure 6. Models of apoD interaction with 5-, 12- and 15-HpETE. ApoD with 5- (cyan carbon atoms) 12- (magenta carbon atoms) and 15-
HpETE (yellow carbon atoms) modeled in the binding site. Met93 is shown. The expanded view illustrates the close proximity of the Met93 side chain
to the HpETE peroxide moiety. The salt bridges between Arg62 and the fatty acid are also indicted in the expanded view as dashed lines.
doi:10.1371/journal.pone.0034057.g006
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After 7 ns, the Met93SO side-chain flipped out of the pocket and
transiently associated with the side-chains of Phe89 and Phe92 in a
similar fashion to native Met93. For the last 30 ns of the
simulation, the side-chain of the oxidized residue was observed to
be surrounded by water molecules and not directly interacting
with other residues. A representative snapshot of this flipped-out
conformation is shown in Figure 9B. The increase in the mobility
of the Met93SO side chain that we have identified increases the
thermal motion of the loop in which it is incorporated and this is
predicted to destabilize apoD structure.
Discussion
The results of the simulation of apoD with progesterone give us
confidence that the CHARMM force-field is sufficiently accurate
to investigate the interactions of this protein with representative
ligands. The simulations of apoD with arachidonate indicate that
this ligand has considerable flexibility. This is consistent with the
structural plasticity of the fatty acid and the broad, open nature of
the apoD binding site, which is ,15 A ˚ deep and 10 A ˚615 A ˚ wide
at the entrance. It is noteworthy that the low-energy conforma-
tions of arachidonate used for the modeling of L-OOHs is similar
to the mode of binding proposed by Eichinger and co-workers [1].
Although the simulations of apoD with arachidonate totaled
800 ns, it may be argued that this timeframe is insufficient for the
system to converge on a global minimum, and that the optimum
binding pose found in nature was not sampled in our simulations.
However, even if such a state exists, fatty acids would be expected
to explore a large number of conformations (such as those
presented here) prior to converging on a hypothetical low-energy
state. Consistent with our experimental results [15], our modeling
indicate that the oxygenated fatty acid products of 5-, 12- and 15-
lipoxygenase bind at the entrance of the ligand binding pocket of
apoD in configurations that would permit direct interaction
between the lipid hydroperoxide moiety and the crucial Met93 side
chain. This interaction occurs as these highly flexible compounds
can slide within the binding-site with many conformations of
similar energy available.
Our data suggest that the solvent-exposed Met93, located in the
hydrophobic region at the opening of the apoD ligand-binding
Figure 7. MD simulation of glycosylated apoD. (A) Schematic
representation of glycosylation patten found at Asn45 and Asn78.
Symbols are: sialic acid (diamonds), mannose (filled circles), galactose
(open circles), N-acetylglucosamine (squares) and fucose (triangle). (B)
Orthogonal views of apoD in ribbon form with progesterone and
methionine residues are represented as van der Waals spheres. The
conformation of the glycosylations, sampled at 1 ns intervals, are
shown (black carbon atoms).
doi:10.1371/journal.pone.0034057.g007
Figure 8. CD spectra of recombinant apoD. Far-UV CD spectra of
apoD and apoD-Met93SO and the Met to Ala mutants indicated. Spectra
were obtained in PBS, pH 7.4 at 22uC.
doi:10.1371/journal.pone.0034057.g008
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phospholipid-bound fatty acid hydroperoxides protrude due to the
addition of the polar peroxide group [27]. The side-chain of
Met157 is buried and therefore not expected to be solvent exposed
to lipid hydroperoxides. However, Met49 is solvent exposed and
therefore has potential to interact with L-OOHs. The simulation
of apoD with physiologically relevant glycosylation suggests that
the ,5 kDa N-linked oligosaccharide at Asn45 could have a
shielding effect on Met49. From our simulation data, this
oligosaccharide is also expected to sterically preclude apoD from
approaching a membrane in an orientation favouring interaction
with Met49. Glycosylation may therefore be one of the
mechanisms by which aberrant oxidation of apoD Met49 is
prevented.
It is noteworthy that apoD Met93 is highly conserved in
mammals (Figure 1) and we speculate that this may afford an
evolutionary advantage in terms of providing a lipid antioxidant
function in the brain and possibly a protective function for the
apoD ligand-binding pocket itself. Relevant to this latter point, the
high propensity for redox-active Met residues to be located in close
proximity to protein ligand binding sites/functional domains has
previously been suggested to confer localized ‘‘guardian’’ antiox-
idant protection [28].
The mechanism underlying the increase in apoD aggregation
that is associated with Met-SO formation [15] is not entirely clear.
Previous research indicates that even though the introduction of
an oxygen atom in the Met side chain would be expected to
decrease the hydrophobicity of the protein (consistent with the
decrease in reversed phase HPLC RT we have reported previously
[15]), this modification can induce structural changes in the
protein that increase the exposure of hydrophobic residues
[29,30]. This prediction is consistent with our simulation of
apoD-Met93SO that suggested the sulfoxide oxygen could initially
accept hydrogen bonds from the amide-nitrogen groups of Phe89
and Ser90 and then flip out of the entrance to the binding pocket to
transiently associate with the side-chains of Phe89 and Phe92 and
then adopt a conformation surrounded by water molecules
without interacting with other residues. Based on previous studies
[31], this may promote local unfolding of the protein structure and
increase the propensity for apoD to self-associate and aggregate.
Previous studies have reported that the destabilization of protein
structure as a consequence of MetSO formation can have
profound functional consequences. The oxidation of p53 Met340
residue located within the hydrophobic core of the p53 tetramer
significantly reduces p53 stability and is thought to represent one
inactivation mechanism for p53 transcriptional function [32].
Interestingly, MD simulations assessing the oxidation of Met213
within Helix-3 of the cellular prion protein (PrP
C) indicated a
destabilization of the PrP
C-like fold that favors more flexible states
that are prone to conformation transition into the pathogenic
infectious prion (PrP
Sc) form [33]. Furthermore, mutations of the
PrP
C that are associated with familial prion disorders increase the
solvent exposure of Met213 and thus increase the probability for
MetSO formation [34]. More directly related to the current study,
previous research has shown that plasma apolipoprotein A-I
(apoA-I) also has the capacity to promote the conversion of L-
OOHs to L-OHs via a 2-electron redox reaction that concom-
itantly converts apoA-I Met residues to their respective MetSO
moieties [35,36]. Recent studies have shown that oxidation of
apoA-I Met residues caused a partial unfolding of the protein,
decreased its thermal stability and promoted its fibrillization [37].
It therefore appears that protein destabilization induced by
selective Met oxidation may be common to several pathogenic
processes.
In summary, our MD simulations provide a plausible
mechanism that helps to explain how different forms of HpETEs
can selectively interact with apoD Met93 and also reveal a
potential basis for the destabilization of and self-association of
apoD structure that results from Met93SO formation.
Figure 9. MD simulation of apoD and apoD-Met93SO. (A)B -
factors calculated from the MD simulations of apoD, apoD-Met93SO and
crystallographic B-factors are shown. (B) Snapshots from the apoD-
Met93SO simulation. Initially the sulfoxide oxygen of Met93SO remains in
the initially modelled conformation, similar to Met93 in the ligand-free
crystal structure. Simulation of apoD-Met93SO suggested that the
sulfoxide oxygen of Met93SO could accept hydrogen bonds from the
amide-nitrogen groups of Phe89 and Ser90. (upper structure). After 7 ns,
the side-chain flips out of the pocket and is surrounded by water
molecules. A representative snapshot of the populations of side-chain
conformations is shown (lower structure).
doi:10.1371/journal.pone.0034057.g009
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